Prognosis

UCD: The average length of survival after UCD diagnosis is greater than 10 years, and life expectancy is usually not changed by UCD.

MCD: The 5-year overall survival rate was 65% in a 2012 literature review. There is reasonable hope that the survival rates are currently greatly improved due to the new breakthroughs in treatment (such as anti-IL6 blockade). The CDCN is currently leading a global patient research study to collect data to update these numbers.

 

Arrow Shape Facebook Instagram Twitter Youtube Play Arrow Left